Zdorovʹe Rebenka (Mar 2016)

Drug Management of Antimicrobial Peptide Production in Cystic Fibrosis in Children

  • O.Ye. Abaturov,
  • V.L. Babych

DOI
https://doi.org/10.22141/2224-0551.2.70.2016.73838
Journal volume & issue
Vol. 11, no. 2.70
pp. 142 – 149

Abstract

Read online

This article provides information about drug management of antimicrobial peptide production in cystic fibrosis in children. The data are provided on the types and classes of mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, and their association with clinical features of cystic fibrosis. The value of antimicrobial peptides in chronic infectious-inflammatory process of the respiratory organs in cystic fibrosis is described. The molecular mechanisms of vitamin D effect on the expression of antimicrobial peptides in the respiratory tract in cystic fibrosis were shown, as well as new limitations of using vitamin D in the therapy of children with this disease were analyzed.

Keywords